Filing metadata

Accession number
0001209191-23-049797
Form type
Form 3
Filer
NGM BIOPHARMACEUTICALS INC
CIK
CIK 1426332
Filed
Sep 18, 2023
Reporting period
Sep 15, 2023
Description
Initial ownership

Explore SEC Filings Hub